ICU

SeaStar Medical Holding Corp

Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. CO· CIK 0001831868 Healthcare & Medical Devices

$2.47 +0.06 (+2.49%)

Oct 26 4:00 PM ET · prev $2.41

Market cap

$15.0M

Nano cap

Median target

$10.00

+305% · range $8.00–12.00

Next earnings

Nov 11

in 16 days · EPS est. −$0.95

1 year

−58.5%

from $5.95 · Oct 27

30 days

−27.4%

from $3.40

52-week range

$2.21–5.95

−58% from high · low Mar 23

Avg volume 20D

270.9K

Oct 7 spike 1.36M

Short interest

🔒 Subscribers only

Insider net

+$2.5K

1 buyer · 0 sellers · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

Reddit crowd

40°

Cool · 1 mention this week

Filing reports

analyzed by SecBot

SecBot read BEARISH 1 report · 90 days

Balance 1 bearish · 0 bullish oldest → newest, height = score

Avg score

·Next Earnings date, Nov 11, 2026

Strongest BEARISH SeaStar Medical entered into a letter agreement with existing warrant holders to induce cash exercise of all…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

R Mar 25 SeaStar Medical reported strong revenue growth for Q4 and full-year…
E Mar 30 FDA: SeaStar Medical Showcases New Positive Data from the QUELI…
X Jul 31 Short interest falls 34.4% to 91.2K
X Aug 14 Short interest jumps 33.5% to 121.7K
B Aug 18 1 insider buy $2.5K at $3.27
R Oct 5 SeaStar Medical entered into a letter agreement with existing warran…

Signal stack

Where each data set points today.

InsidersBULLISH

1 insider bought $2.5K at an average $3.27. No open-market sales. Price is 24% below their cost.
InstitutionsMIXED

Q2 2026: 2 added (0 new), 1 trimmed or exited.
EstimatesFALLING

Current-quarter EPS estimate −$0.895 → −$0.950 over 90 days. 0 up, 2 down in 30 days.
TrendDOWNTREND

24% below its 50-day average.
SocialQUIET

Crowd 40° (cool) this week from 1 mention: 0 bullish, 1 bearish. No setup call.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
UBS Group AG	DOUBLED	31,398	$115.2K
JANE STREET GROUP, LLC	TRIM	12,634	$46.4K
PNC FINANCIAL SERVICES GROUP, INC.	DOUBLED	4,943	$18.1K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action May 2026

12-month targets · 2 analysts

$2.47 $8.00 $10.00 $12.00

Price is below the lowest target. Median implies +305%.Targets as of Oct 26, 2026.

Recent actions

Date	Firm	Action	Rating
May 14, 2026	Maxim Group MAINTAIN	MAINTAIN	Buy

Catalysts

Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.

Upcoming

Nov 11, 2026

Earnings date

ICU Q3 2026 Earnings Scheduled — 2026-11-11

Recent

Oct 22, 2026

Press release

SeaStar Medical Reports Statistically Significant Survival Findings from Post-Approval QUELIMMUNE® SAVE Registry Analysis in Pediatric Sepsis-Associated AKI

New late-breaking data presented today at ASN Kidney Week 2026 QUELIMMUNE (SCD-PED) treatment group demonstrates statistically significant higher…

Oct 2, 2026

Press release

SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026

DENVER, Oct. 02, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on…

Oct 1, 2026

Press release

New ICD-10-PCS Codes are Now Available for the Use of SeaStar Medical’s SCD Therapy for Acute Kidney Injury (AKI)

New codes streamline hospital billing, enable tracking of clinical outcomes, and expand access to QUELIMMUNE ® (SCD-PED) therapy

Sep 29, 2026

Press release

SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026

Dr. Chung to deliver an oral presentation highlighting QUELIMMUNE ® , an advanced extracorporeal therapy for critically ill pediatric patients with…

Sep 24, 2026

Press release

SeaStar Medical Congratulates H. David Humes, M.D., on Receiving the University of Michigan 2026 Distinguished University Innovator of the Year for Development of the SCD Therapy

Prestigious honor recognizes Dr. Humes’ pioneering work in developing the Selective Cytopheretic Device (SCD) therapy, commercialized by SeaStar…

Insider ledger

Form 4

$2.5K

bought · 1 insider

sold · 0 insiders

−24.5%

vs their $3.27 cost

Date	Insider	Type	Value
Aug 18, 2026	Messinger Michael Chief Financial Officer	BUY	$2.5K
Jul 1, 2026	Schlorff Eric Chief Executive Officer	AWARD	10,288 sh
Jul 1, 2026	Chung Kevin Chief Medical Officer	AWARD	7,202 sh
Jul 1, 2026	Van Heel Kenneth Director	AWARD	4,000 sh
Jul 1, 2026	Baird Jennifer A Director	AWARD	4,000 sh
Jul 1, 2026	Vincent Bernadette N Director	AWARD	4,000 sh
Jul 1, 2026	Neuman John Director	AWARD	4,000 sh
Feb 6, 2026	Baird Jennifer A Director	AWARD	3,000 sh

Earnings setup

Estimates

Nov 11

reports in 16 days

−$0.95

EPS estimate, this quarter

−6%

estimate change, 90 days

0↑ 2↓

revisions, 30 days

Current-quarter EPS estimate

−$0.895

90d

−$0.950

60d

−$0.950

30d

−$0.950

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	-$0.95	-$0.95–-$0.95	+0.0%	$500.0K
Next Q	-$0.89	-$0.89–-$0.89	+0.0%	$500.0K
Current FY	-$3.66	-$3.66–-$3.66	+0.0%	$2.0M
Next FY	-$2.33	-$2.58–-$2.09	+0.0%	$2.9M

Short side

FINRA· Oct 15, 2026

🔒 Subscribers only

shares short

Recent activity

The latest filings, insider trades, analyst actions, press and options flow — newest first.

Oct 22, 2026 Other

SeaStar Medical Reports Statistically Significant Survival Findings from Post-Approval QUELIMMUNE® SAVE Registry Analysis in Pediatric Sepsis-Associated AKI

New late-breaking data presented today at ASN Kidney Week 2026 QUELIMMUNE (SCD-PED) treatment group

Oct 5, 2026 SEC

SeaStar Medical entered into a letter agreement with existing warrant holders to induce cash exercise of all…

8-K — Impact 6/10

Aug 18, 2026 Insider

Messinger Michael bought 750 shares

Chief Financial Officer @ $3.27 ($2.5K)

Jul 1, 2026 Insider

Schlorff Eric was granted 10,288 shares

Chief Executive Officer

Jul 1, 2026 Insider

Chung Kevin was granted 7,202 shares